CCRM Nordic today announces the appointment of Nina Herne as Chief Operating Officer (COO), strengthening the organization’s leadership team as it continues to scale its role as a Nordic catalyst and key infrastructure for advanced therapies.
Nina Herne brings extensive executive experience from leading life science and biotech organisations across the full value chain; from early research and development to late-stage clinical development and commercialisation. She has held senior leadership roles in both small and global companies, with deep expertise in strategy, corporate development, operations and organizational transformation.
She holds a PhD in Immunology from Lund University and an Executive MBA from Stockholm School of Economics and has extensive board and governance experience. Nina is also a member of the Steering Committee of the SciLifeLab Drug Discovery and Development (DDD) Platform.
“Nina brings a rare combination of scientific depth, operational excellence and strategic leadership,” says Fredrik Wessberg, CEO of CCRM Nordic. “She understands what it takes to build robust organisations that can support development from early innovation through to clinical and commercial readiness. As we continue to scale CCRM Nordic, Nina is exactly the leader we need to strengthen our operational platform and deliver long-term impact for patients, partners and the wider ecosystem.”
In her role as COO, Nina will be responsible for strengthening CCRM Nordic’s operational capabilities, while supporting the organisation’s long-term strategic growth and mission to accelerate the development and accessibility of advanced therapies.
“I am excited to join CCRM Nordic at this stage of transformation, both for the organization and for the evolving ATMP landscape. I look forward to su pporting companies on their journey to market and facilitating earlier patient access to these important and potentially life-changing therapies.”
CCRM Nordic is a Nordic centre of excellence supporting the development, manufacturing and commercialization of advanced therapies, working closely with innovators, industry, academia and healthcare partners.
For more information, please contact:
Fredrik Wessberg
CEO, CCRM Nordic
fredrik.wessberg@ccrmnordic.se
+46 722–296905